JOURNAL OF LEUKOCYTE BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2024-08-26 doctor7542 来自安徽省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：血液肿瘤
经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2021-05-10 ms4000001794871966

偏重的研究方向：血液学
经验分享：一个月了还在under review 好着急啊

135 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2019-08-05 ms9740844126549404

杂志审稿很快、审稿人很nice！

169 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2022-04-14 ms1000000412772608

偏重的研究方向：Immunology;Cancer
经验分享：有人在这个杂志投综述吗？容易中吗

124 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2022-03-17 嗨嗨嗨海海海

有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？

129 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2022-07-16 嗨嗨嗨海海海

偏重的研究方向：Immunology;免疫
经验分享：谁知道这个杂志社版面费怎么交啊？？请指点

102 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

俢回的流程是什么？

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2021-12-28 MS54455111222

审稿的流程是什么？

104 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2021-11-08 12182398m36(暂无昵称)

这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?

122 0

[GetPortalCommentsPageByObjectIdResponse(id=2222443, encodeId=b520222244386, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：血液肿瘤 经验分享：总体进度还行，5.30投稿，7.24小修，8.3修回，8.24接收。审稿人很专业，提的问题不是很多，比较顺利吧，与文章的新意和工作量可能相关，感觉投的有点亏，哈哈。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7UnYTmSXTnon5smbXoibXTcia43jok1Tia6gZGh8HCGh2IgI8CnjXlxLxIF1oLbCibLaKJB3W2zDbltA/0, createdBy=01181975893, createdName=doctor7542, createdTime=Mon Aug 26 11:37:48 CST 2024, time=2024-08-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=964293, encodeId=9b0c964293e6, content=偏重的研究方向：血液学 经验分享：一个月了还在under review 好着急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45a65475599, createdName=ms4000001794871966, createdTime=Mon May 10 14:53:01 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852987, encodeId=cb3c85298e38, content=杂志审稿很快、审稿人很nice！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83d75413971, createdName=ms9740844126549404, createdTime=Mon Aug 05 11:27:19 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211022, encodeId=b6531211022dc, content=偏重的研究方向：Immunology;Cancer 经验分享：有人在这个杂志投综述吗？容易中吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edba5640261, createdName=ms1000000412772608, createdTime=Thu Apr 14 00:37:19 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203312, encodeId=1c2b1203312a7, content=有人知道二审时间多久吗？交完修改稿，系统又重新开始算审稿时间了。一般二审什么流程呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Thu Mar 17 00:12:34 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232800, encodeId=bbc9123280085, content=偏重的研究方向：Immunology;免疫 经验分享：谁知道这个杂志社版面费怎么交啊？？请指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4b5706991, createdName=嗨嗨嗨海海海, createdTime=Sat Jul 16 15:13:28 CST 2022, time=2022-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093497, encodeId=1653109349ead, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093498, encodeId=15ba10934985b, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068148, encodeId=51731068148bf, content=这个杂志到底收多少钱啊，Wiley上说OA是可选，但是投稿系统里直接有一个Open Access Licensing，只能选Yes，这是代表同意开放存取的意思吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fe72260449, createdName=12182398m36(暂无昵称), createdTime=Mon Nov 08 16:16:19 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585198, encodeId=da22585198fb, content=请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表: 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后 投这个就中了。老板觉得比较专业。 我们实验室有投这个没中，投了5分以上综合类反而中了, beContent=apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39222278445, createdName=121bddc4m20(暂无昵称), createdTime=Sat Feb 22 00:00:00 CST 2020, time=2020-02-22, status=1, ipAttribution=)]

2020-02-22 121bddc4m20(暂无昵称)

请问投的哪个5分的综合杂志呢apoptosiser 2016-02-17 发表::
接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了apoptosiser 2016-02-17 15:54:00 发表:
比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后
投这个就中了。老板觉得比较专业。
我们实验室有投这个没中，投了5分以上综合类反而中了

apoptosiser 2016-02-17 发表:: 接收率：约50% 审稿时间：约1个月 SCI(2014)：4.289 比较有意思的杂志，审稿人比较友善，比几个5分的强多了。投了好几个5分被拒后投这个就中了。老板觉得比较专业。我们实验室有投这个没中，投了5分以上综合类反而中了

218 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务